Gliatech Investigating Adcon-L Study Data Issues Raised By FDA Inspection
Gliatech intends to respond to inspectional observations contained in a FDA-issued Form 483 by Sep. 14.
Gliatech intends to respond to inspectional observations contained in a FDA-issued Form 483 by Sep. 14.